SCHEMBL9952407

SCHEMBL9952407

CCCCCc1ccc2c(c1)sc1c3ccc(CCCCC)cc3sc21

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 2/20 0.43
ADRA2A P08913 2/20 0.43
ADORA3 P0DMS8 2/20 0.43
TACR2 P21452 2/20 0.43
SLC6A2 P23975 2/20 0.43
SLC6A4 P31645 2/20 0.43
SLC6A3 Q01959 2/20 0.43
KDM4E B2RXH2 2/20 0.43
CYP3A4 P08684 2/20 0.43
PTGS2 P35354 2/20 0.43
ALDH1A1 P00352 1/20 0.43
LMNA P02545 1/20 0.43
SHBG P04278 1/20 0.43
TP53 P04637 1/20 0.43
HSPD1 P10809 1/20 0.43
ADRB3 P13945 1/20 0.43
HTR2C P28335 1/20 0.43
HSPE1 P61604 1/20 0.43
HIF1A Q16665 1/20 0.43
TST Q16762 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10031386 0.98 PTGS2 (0.46) ESR1ADRA2AADORA3TACR2SLC6A2
SCHEMBL708808 0.98 PTGS2 (0.46) ESR1ADRA2AADORA3TACR2SLC6A2
SCHEMBL31318821 0.98 PTGS2 (0.46) ESR1ADRA2AADORA3TACR2SLC6A2
SCHEMBL30423034 0.98 PTGS2 (0.46) ESR1ADRA2AADORA3TACR2SLC6A2
SCHEMBL709940 0.98 PTGS2 (0.46) ESR1ADRA2AADORA3TACR2SLC6A2
SCHEMBL1105095 0.98 PTGS2 (0.46) ESR1ADRA2AADORA3TACR2SLC6A2
SCHEMBL14692999 0.97 ESR1 (0.41) ESR1ADRA2AADORA3TACR2SLC6A2
SCHEMBL14997940 0.95 ESR1 (0.43) ESR1ADRA2AADORA3TACR2SLC6A2
SCHEMBL11892333 0.95 ESR1 (0.43) ESR1ADRA2AADORA3TACR2SLC6A2
SCHEMBL16070298 0.95 ESR1 (0.43) ESR1ADRA2AADORA3TACR2SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10964919-B2 Organic electroluminescent transistor FLEXTERRA INC. (US) 2021-03-30 US disclosed
EP-3172778-B1 ORGANIC ELECTROLUMINESCENT TRANSISTOR E T C SRL (IT) 2018-10-03 EP disclosed
US-9825261-B2 Organic electroluminescent transistor FLEXTERRA, INC. (US) 2017-11-21 US disclosed
US-20170237043-A1 Organic Electroluminescent Transistor USINVEST LLC 2017-08-17 US disclosed
US-20170237042-A1 Organic Electroluminescent Transistor USINVEST LLC 2017-08-17 US disclosed
US-9680112-B2 Semiconductor composition SAMSUNG ELECTRONICS CO., LTD. (KR) 2017-06-13 US disclosed
US-9680112-B2 Semiconductor composition SAMSUNG ELECTRONICS CO., LTD. (KR) 2017-06-13 US disclosed
US-9680112-B2 Semiconductor composition SAMSUNG ELECTRONICS CO., LTD. (KR) 2017-06-13 US disclosed
EP-3172778-A1 ORGANIC ELECTROLUMINESCENT TRANSISTOR E.T.C. S.r.l. (IT) 2017-05-31 EP disclosed
WO-2016014980-A1 ORGANIC ELECTROLUMINESCENT TRANSISTOR E.T.C.S.R.L. (IT) 2016-01-28 WO disclosed
US-8643001-B2 Semiconductor composition SAMSUNG ELECTRONICS CO. LTD. (KR) 2014-02-04 US disclosed
US-8643001-B2 Semiconductor composition SAMSUNG ELECTRONICS CO. LTD. (KR) 2014-02-04 US disclosed
US-8643001-B2 Semiconductor composition SAMSUNG ELECTRONICS CO. LTD. (KR) 2014-02-04 US disclosed
US-20120313081-A1 ELECTRONIC DEVICE XEROX CORPORATION (US) 2012-12-13 US disclosed
US-20120261648-A1 SEMICONDUCTOR COMPOSITION XEROX CORPORATION (US) 2012-10-18 US disclosed
US-20120261648-A1 SEMICONDUCTOR COMPOSITION XEROX CORPORATION (US) 2012-10-18 US disclosed
US-20120261648-A1 SEMICONDUCTOR COMPOSITION XEROX CORPORATION (US) 2012-10-18 US disclosed
US-20120161110-A1 SEMICONDUCTOR COMPOSITION XEROX CORPORATION (US) 2012-06-28 US disclosed
US-20120161110-A1 SEMICONDUCTOR COMPOSITION XEROX CORPORATION (US) 2012-06-28 US disclosed
US-20120161110-A1 SEMICONDUCTOR COMPOSITION XEROX CORPORATION (US) 2012-06-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10964919-B2 Organic electroluminescent transistor EML4, IPO4, BRI3BP ESR1 1216/4885ADRA2A 3380/4885ADORA3 1671/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.